awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37216507-121A0083-BDF2-4ACC-AE77-7509E1A8F2CE
Q37216507-121A0083-BDF2-4ACC-AE77-7509E1A8F2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37216507-121A0083-BDF2-4ACC-AE77-7509E1A8F2CE
SASLT guidelines: Update in treatment of Hepatitis C virus infection.
P2860
Q37216507-121A0083-BDF2-4ACC-AE77-7509E1A8F2CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37216507-121A0083-BDF2-4ACC-AE77-7509E1A8F2CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e2f650988df6845075c00200c6ea4650cafcb02
P2860
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a